Correction to: Switching from natalizumab to fingolimod treatment in multiple sclerosis: real life data from the Austrian MS Treatment Registry
Crossref DOI link: https://doi.org/10.1007/s00415-019-09535-2
Published Online: 2019-09-17
Published Print: 2019-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Guger, Michael
,
Enzinger, Christian
Leutmezer, Fritz
Kraus, Jörg
Kalcher, Stefan
Kvas, Erich
Berger, Thomas
Text and Data Mining valid from 2019-09-17
Version of Record valid from 2019-09-17
Article History
First Online: 17 September 2019
Free to read: This content has been made available to all.